Wednesday, October 31, 2012

GUIDE: HOW TO MAKE YOUR OWN DEODERANT

Posted on by Sonnet Lauberth: Holistic Health Coach, For The Love of Food Blog
 Guide: How to Make Your Own Deodorant
For many years deodorant has been the bane of my existence.  As a teenager I learned that there is a strong connection between the aluminum in deodorant and Alzheimer’s disease.  As a result, I was committed to using only natural deodorants.  I have tried every stick, spray, roll-on, and crystal I could find. The result? Disappointment.  I hate to say it, but I never found a product that worked for longer than an hour.  In my frustration I found my way back to using conventional deodorant, stressing with each application about what I was putting into my body.
Then I  heard from a friend that if you didn’t use deodorant for a period of time your body will naturally adjust to it and you wouldn’t need to use it.  Let’s just say I tried that for a week and it was a failed experiment.  And gross.
After searching around the internet, I discovered there are a ton of DIY deodorant recipes that use natural ingredients like baking soda, corn starch, and coconut oil.  I have tried several different batches of homemade deodorant using different proportions of these ingredients and different essential oils.  My first batch used peppermint oil which irritated my skin, my second batch had too much baking soda which also irritated my skin, but this final batch?  Just right.
Since I live in a colder climate, coconut oil is usually solid (except in summer) so I had to gently heat it to a liquid so I could mix my ingredients.  When it cooled again, my deodorant was a solid gel.  I’ve heard mixed reviews from others who have put homemade deodorant into empty twist-up deodorant containers – some say it crumbles while others think it works fine.  I haven’t tried this myself because I think it’s easier to keep the deodorant in a small jar and apply by hand.  If you live in a warm climate, your mixture might not solidify (unless you keep it in the fridge) so it will be even easier to apply by hand because it will be in a liquid state.
I have been super impressed with how well this deodorant works and it actually works better for me than conventional deodorant.  I think I have to say that again.  It actually works better than conventional deodorant – the ones with the aluminum!  If only I had known about this years ago. Sigh. I guess the perfect deodorant search is over.
DIY Deodorant
  • 1/4 cup coconut oil
  • 2 Tablespoons corn starch*
  • 1 Tablespoon + 1 teaspoon baking soda*
  • 20 – 25 drops lavender essential oil
Directions:
  1. Melt your coconut oil (if necessary) and mix with the corn starch and baking soda.
  2. Add the essential oil.
  3. Mix.
  4. Transfer to a glass container.
  5. Use up!
  6. Will last 2 -3 months depending on usage.
*Notes: My batch has less baking soda and corn starch than some recipes I’ve seen because I experienced skin irritation from these ingredients at a higher ratio.  If this mixture is not effective for you, you can increase the amount of baking soda and corn starch by about 2 teaspoons.
http://www.onegreenplanet.org/lifestyle/guide-how-to-make-your-own-deodorant/

Friday, October 26, 2012

PROSTRATE CANCER TESTS 'MORE HARM THAN GOOD

ABC October 27, 2012,
A group representing Australian general practitioners says the risks of being screened for prostate cancer outweigh the benefits.
In its latest book of preventative health guidelines, the Royal Australian College for GPs advises its members not to recommend prostate cancer screening to patients.
Professor Chris Del Mar from Bond University on the Gold Coast says the process is invasive and can lead to health problems.
"To find out whether you've got it involves an involved diagnostic procedures, a biopsy done through the rectum into the prostate," Professor Del Mar said.
While there's a 50 per cent chance men over the age of 60 will have the disease, Professor Del Mar says prostate cancer is entirely benign in most cases.
Professor Del Mar says if he had the disease, he would not want to know.
"The chances are - still - that it won't ever shorten my life," he said.
He says patients who are tested often develop serious infections, erectile dysfunction and urinary incontinence.
Professor Del Mar says he is concerned about public awareness campaigns encouraging men to be screened for prostate cancer.
"There's a lot of confusion in the minds of GPs and the general public," he said.
"Screening for prostate cancer ends up doing more harm than good."
The college has always opposed screening for prostate cancer and says, increasingly, medical literature supports its position.
http://au.news.yahoo.com/latest/a/-/latest/15231774/prostate-cancer-tests-more-harm-than-good/

Tuesday, October 23, 2012

DRUG COMPANY CHIEF: OUR DRUGS DO NOT WORK ON MOST PATIENTS



by Steve Connor
A senior executive with Britain's biggest drugs company has admitted that most prescription medicines do not work on most people who take them.
Allen Roses, worldwide vice-president of genetics at GlaxoSmithKline (GSK), said fewer than half of the patients prescribed some of the most expensive drugs actually derived any benefit from them.
It is an open secret within the drugs industry that most of its products are ineffective in most patients but this is the first time that such a senior drugs boss has gone public. His comments come days after it emerged that the NHS drugs bill has soared by nearly 50 per cent in three years, rising by £2.3bn a year to an annual cost to the taxpayer of £7.2bn. GSK announced last week that it had 20 or more new drugs under development that could each earn the company up to $1bn (£600m) a year.
Dr Roses, an academic geneticist from Duke University in North Carolina, spoke at a recent scientific meeting in London where he cited figures on how well different classes of drugs work in real patients. Drugs for Alzheimer's disease work in fewer than one in three patients, whereas those for cancer are only effective in a quarter of patients. Drugs for migraines, for osteoporosis, and arthritis work in about half the patients, Dr Roses said. Most drugs work in fewer than one in two patients mainly because the recipients carry genes that interfere in some way with the medicine, he said.
"The vast majority of drugs - more than 90 per cent - only work in 30 or 50 per cent of the people," Dr Roses said. "I wouldn't say that most drugs don't work. I would say that most drugs work in 30 to 50 per cent of people. Drugs out there on the market work, but they don't work in everybody."
Some industry analysts said Dr Roses's comments were reminiscent of the 1991 gaffe by Gerald Ratner, the jewelry boss, who famously said that his high street shops are successful because they sold "total crap". But others believe Dr Roses deserves credit for being honest about a little-publicized fact known to the drugs industry for many years.
"Roses is a smart guy and what he is saying will surprise the public but not his colleagues," said one industry scientist. "He is a pioneer of a new culture within the drugs business based on using genes to test for who can benefit from a particular drug."
Dr Roses has a formidable reputation in the field of "pharmacogenomics" - the application of human genetics to drug development - and his comments can be seen as an attempt to make the industry realize that its future rests on being able to target drugs to a smaller number of patients with specific genes.
The idea is to identify "responders" - people who benefit from the drug - with a simple and cheap genetic test that can be used to eliminate those non-responders who might benefit from another drug.
This goes against a marketing culture within the industry that has relied on selling as many drugs as possible to the widest number of patients - a culture that has made GSK one of the most profitable pharmaceuticals companies, but which has also meant that most of its drugs are at best useless, and even possibly dangerous, for many patients.
Dr Roses said doctors treating patients routinely applied the trial-and-error approach which says that if one drug does not work there is always another one. "I think everybody has it in their experience that multiple drugs have been used for their headache or multiple drugs have been used for their backache or whatever.
"It's in their experience, but they don't quite understand why. The reason why is because they have different susceptibilities to the effect of that drug and that's genetic," he said.
"Neither those who pay for medical care nor patients want drugs to be prescribed that do not benefit the recipient. Pharmacogenetics has the promise of removing much of the uncertainty."
Response rates
Therapeutic area: drug efficacy rate in per cent
  • Alzheimer's: 30
  • Analgesics (Cox-2): 80
  • Asthma: 60
  • Cardiac Arrhythmias: 60
  • Depression (SSRI): 62
  • Diabetes: 57
  • Hepatitis C (HCV): 47
  • Incontinence: 40
  • Migraine (acute): 52
  • Migraine (prophylaxis): 50
  • Oncology: 25
  • Rheumatoid arthritis: 50
  • Schizophrenia: 60
Originally published on Monday, December 8, 2003 by the lndependent/UK
Webmaster's notes:
"Response rate", an often misused term.  It has nothing to do with actual cure rate, and it does not necessarily indicate any significant improvement or symptom alleviation. It only means that some kind of positive response was observed, however small it may have been. When it comes to cancer, the term "response rate" is often abused to sell patients on expensive chemotherapy drugs or other mainstream treatments which often have extremely poor success rates.
The GSK vice-president blamed the drugs failure on genetics.  Yes, there must be something about natural human genetics which does not respond well to unnatural chemical compounds which attempt to force the body to function abnormally to repress symptoms of illness and in the process create more medical conditions and the need for more and more drugs.  As opposed to natural herbs, vitamins, minerals and other nutrients which help the body function normally and help prevent and actually cure illness by addressing the root causes instead of just symptoms.